The explosive popularity of GLP-1 drugs like Ozempic, Wegovy and Zepbound is transforming the way Americans treat obesity, with demand soaring beyond doctors’ offices and into online marketplaces, med spas and unregulated gray-market vendors. And while the medications are helping many people lose significant weight and improve their health, one Madison doctor warns the trend is outpacing the science.
Office of Strategic Communication